You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AMBISOME Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ambisome, and what generic alternatives are available?

Ambisome is a drug marketed by Astellas and is included in one NDA.

The generic ingredient in AMBISOME is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ambisome

A generic version of AMBISOME was approved as amphotericin b by XGEN PHARMS on April 29th, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMBISOME?
  • What are the global sales for AMBISOME?
  • What is Average Wholesale Price for AMBISOME?
Summary for AMBISOME
Drug patent expirations by year for AMBISOME
Drug Prices for AMBISOME

See drug prices for AMBISOME

Recent Clinical Trials for AMBISOME

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
F2G Biotech GmbHPhase 3
Iqvia Pty LtdPhase 3
Dongkook Pharmaceutical Co., Ltd.Phase 1

See all AMBISOME clinical trials

Pharmacology for AMBISOME

US Patents and Regulatory Information for AMBISOME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas AMBISOME amphotericin b INJECTABLE, LIPOSOMAL;INJECTION 050740-001 Aug 11, 1997 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AMBISOME

See the table below for patents covering AMBISOME around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 115393 ⤷  Sign Up
Ireland 872148 ⤷  Sign Up
Ireland 62110 Improved amphotericin B liposome preparation ⤷  Sign Up
Japan H01160915 IMPROVED METHOD FOR PREPARATION OF AMPHOTERICIN B ⤷  Sign Up
European Patent Office 0260811 ⤷  Sign Up
Australia 598958 ⤷  Sign Up
Denmark 175052 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.